| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-19 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-11 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-10 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-10 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-10 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-09 |